A randomized, double blind, crossover study comparing Pliaglis (lidocaine/tetracaine) cream 7 percent/7 percent to placebo cream when applied for 60 minutes in the treatment of patients with postherpetic neuralgia.
Phase of Trial: Phase II
Latest Information Update: 14 Mar 2012
At a glance
- Drugs Lidocaine/tetracaine (Primary)
- Indications Neuropathic pain; Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors ZARS Pharma
- 14 Mar 2012 Actual patient number (23) added as reported by ClinicalTrials.gov.
- 02 Oct 2008 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
- 02 Oct 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov.